Public Company News

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

SUZHOU, China, March 23, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the European Medicines Agency (EMA) for sugemalimab. T...

2025-03-24 08:15 2951

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation of SCB-1019 as part of a respiratory combination Trimer-Tagged PreF vaccine (RSV + hMPV ± PIV3...

2025-03-24 07:56 2350

Lion Announces Plan to Implement ADS Ratio Change

HONG KONG, March 21, 2025 /PRNewswire/ -- Lion Group Holding Ltd. ("Lion" or "the Company") (NASDAQ: LGHL), operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs")...

2025-03-22 04:05 4812

MicroAlgo Inc. plans to issue additional new shares at an offering price of $0.8 per share.

SHENZHEN, China, March 21, 2025 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ: MLGO), (the "Company"or "MicroAlgo"), today announced the plan to issue more new shares,considering that MicroAlgo Inc. entered into a convertible bond purchase agreement with creditors onOctober 7, 2024, with a total amount ...

2025-03-22 01:30 4991

MicroCloud Hologram Inc. Files 2024 Annual Report on Form 20-F

SHENZHEN, China, March 21, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (Nasdaq: HOLO) ("MicroCloud" or the "Company") today filed its operational and financial results for the fiscal year endedDecember 31, 2024, on Form 20-F with the U.S. Securities and Exchange Commission (the "SEC"). MicroClo...

2025-03-22 00:45 2812

The Emotional Evolution of the Intelligent Era: Tuya Smart and DeepSeek Lead the Future of AI-driven Companionship

NEW YORK, March 21, 2025 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, is redefining the role of AI in the smart home ecosystem, turning cold technology into an emotionally intelligent companion. Imagine returning home after a long day, your mi...

2025-03-21 21:49 3320

HUYA Inc. Provides Update on Share Repurchase Program

GUANGZHOU, China, March 21, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today provided an update on its ongoing share repurchase program in response to investor inquiry. As previously disclosed, under this program, the Com...

2025-03-21 20:15 2569

4BY4 to Showcase AI Video Solution 'PIXELL' at NAB 2025 with 8K Association

SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- 4BY4, a leading AI-driven content solution company, has announced its participation in the upcoming2025 NAB Show (National Association of Broadcasters Show)taking place from April 5 to 9 in Las Vegas, the world's largest exhibition for broadcasti...

2025-03-21 20:00 2399

Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

XIAMEN, China, March 21, 2025 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company received a notification letter (the "Notification Letter") from the Listing Qualifications De...

2025-03-21 20:00 2574

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, today announced a global ...

2025-03-21 19:21 2625

51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2024

SINGAPORE, March 21, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the fourth quarter and full year endedDecember 31, 2024. Full...

2025-03-21 18:10 3820

China Yuchai Subsidiary Adopts Equity Incentive Plan

SINGAPORE, March 21, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), today announced an equ...

2025-03-21 18:00 3069

Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting

HONG KONG, March 20, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4 bispecific ...

2025-03-21 11:14 2350

BUMA Completes Inaugural Sukuk Issuance, the Largest A+ Sharia-Rated Corporate Sukuk Ijarah in a Single Issuance in Indonesia[1]

* BUMA has successfully completed the issuance of its inaugural Sukuk Ijarah I BUMA 2025, with a total value ofRp2 trillion, making it the Largest A+ Sharia-rated corporate Sukuk Ijarah in a single issuance inIndonesia[2]. * The Sukuk was oversubscribed by 1.1x, reflecting strong investor dema...

2025-03-21 10:57 2409

WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year

* Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) * Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all SHANGHAI, March 20, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2...

2025-03-21 08:30 2145

Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025

* Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare Opportunities YONGIN, South Korea, March 20, 2025 /PRNewswire/ -- Noul Co., Ltd.  a Korea-based medical AI company, announced that it presen...

2025-03-21 00:00 3526

SINEXCEL Recognized as a Tier 1 Low-Voltage Power Quality Supplier

SHENZHEN, China, March 20, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ), a global pioneer in power quality, energy storage and EV charging solutions, has been recognized by Wintelligence, a leading industrial research and consulting firm, as a Tier 1 Low-Voltage Power Quality Supplier inChina. This ...

2025-03-20 21:00 2311

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025

-    Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary HPV congress held inPortugal from March 16-19 -    Demonstrated how self-collected samples for HPV testing can bridge gaps in cervical cancer screening and advance HPV screening goals SEOUL, South K...

2025-03-20 21:00 2335

Cheche Group Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date

BEIJING, March 20, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss fourth quarter and full year 2024 results on Friday,...

2025-03-20 20:00 3637

TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development

* Clinical Trial Approval of merigolix (TU2670, HS-10518) for the inhibition of premature LH (luteinizing hormone) surges in women undergoing COS (controlled ovarian stimulation) inChina SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- TiumBio (KOSDAQ: 321550), a clinical-stage biopharmace...

2025-03-20 20:00 2112
1 ... 138139140141142143144 ... 772

Week's Top Stories